AI assistant
RHYTHM PHARMACEUTICALS, INC. — Director's Dealing 2023
Mar 6, 2023
30849_dirs_2023-03-06_e2ac3fa6-3933-4a85-b6b6-8bea634df3f4.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: RHYTHM PHARMACEUTICALS, INC. (RYTM)
CIK: 0001649904
Period of Report: 2023-03-02
Reporting Person: Mathers Edward T (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2023-03-02 | Common Stock | J | 5771 | $0.00 | Acquired | 5771 | Indirect |
Footnotes
F1: The Edward Timothy Mathers Revocable Trust (the "Mathers Trust") received 5,771 shares of Common Stock of the Issuer in the distribution by NEA Partners 13, L.P. on March 2, 2023.
F2: The Reporting Person is the trustee of the Mathers Trust, which is the direct beneficial owner of the securities. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the 1934 Act, as amended, or otherwise of such portion of the securities held by the Mathers Trust in which
the Reporting Person has no pecuniary interest.